The Core Concept We are securing the body’s "manufacturing plant" (Hematopoietic Stem Cells) by precision-targeting the three drivers of stem cell exhaustion: Telomeric Deregulation (TERRA ASOs), Anabolic Overheat (Hyperactive mTOR), and Oxidative Corrosion (Shelterin damage). This is about preserving the genetic master copies so the blood system doesn't print errors.

Why This Works Systemic telomere therapies often fail because of the "Goldilocks" problem: too little does nothing, too much causes cancer. Furthermore, treating the whole body dilutes the effect where it matters most: the bone marrow.

The VIP Pass (CD117-LNPs): We solve the delivery problem by using CD117 antibodies to guide Lipid Nanoparticles exclusively to HSCs. We deliver anti-TERRA ASOs to "tune" the telomeric chromatin—optimizing the protective cap without triggering uncontrolled growth.

The Cool-Down (NEBI): By pulsing mTOR inhibition, we force the stem cells into a temporary "maintenance mode" (quiescence), preventing the replicative exhaustion that comes from constant activation.

The Rust-Proofing (THIO): We use sodium thiosulfate to drive persulfidation, chemically shielding the delicate shelterin proteins from oxidative rust.

The Test We treat 19-month-old mice (late middle age) with this targeted "Tune, Pause, & Shield" regimen for 4 months.

The Win Condition: If we see a >25% increase in HSC repopulation capacity and a 20% median lifespan extension, we prove that immune aging isn't just about time—it's about the physical integrity of the manufacturing equipment. Protect the press, and you protect the product.